Lynx1 Capital Management LP Diversified Active

CIK: 0001910456 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value ($000): $254,318 (100.0% shares, 0.0% debt)

Holdings (15)

— ALPINE IMMUNE SCIENCES INC 28.6%

Value ($000) $72,693 Shares 3,813,926 Est. Cost $13.47 Unrealized —

CABA CABALETTA BIO INC 18.8%

Value ($000) $47,906 Shares 2,110,401 Est. Cost $3.64 Unrealized +361.8%

— MERUS N V 12.3%

Value ($000) $31,219 Shares 1,135,225 Est. Cost $24.66 Unrealized —

TCRX TSCAN THERAPEUTICS INC 12.0%

Value ($000) $30,459 Shares 5,224,600 Est. Cost $2.68 Unrealized +70.9%

CCCC C4 THERAPEUTICS INC 7.0%

Value ($000) $17,709 Shares 3,134,396 Est. Cost $2.53 Unrealized -9.9%

STOK STOKE THERAPEUTICS INC 6.1%

Value ($000) $15,553 Shares 2,956,918 Est. Cost $5.61 Unrealized -23.7%

AUTL AUTOLUS THERAPEUTICS PLC 4.7%

Value ($000) $11,968 Shares 1,858,409 Est. Cost $3.43 Unrealized —

GHRS GH RESEARCH PLC 4.2%

Value ($000) $10,664 Shares 1,838,617 Est. Cost $9.07 Unrealized -22.2%

— KINNATE BIOPHARMA INC 1.9%

Value ($000) $4,733 Shares 1,997,006 Est. Cost $10.62 Unrealized —

SLN SILENCE THERAPEUTICS PLC 1.6%

Value ($000) $4,096 Shares 235,787 Est. Cost $9.82 Unrealized —

— THESEUS PHARMACEUTICALS INC 1.1%

Value ($000) $2,845 Shares 702,415 Est. Cost $8.59 Unrealized —

— PIERIS PHARMACEUTICALS INC 0.7%

Value ($000) $1,779 Shares 9,775,849 Est. Cost $1.23 Unrealized —

— BIONOMICS LIMITED 0.5%

Value ($000) $1,220 Shares 824,305 Est. Cost $2.69 Unrealized —

— NEKTAR THERAPEUTICS 0.4%

Value ($000) $1,090 Shares 1,929,198 Est. Cost $0.59 Unrealized —

— PASSAGE BIO INC 0.2%

Value ($000) $383 Shares 379,159 Est. Cost $1.22 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ALPINE IMMUNE SCIENCES INC	3,813,926	$72,693	28.6%	$13.47	—	COM	02083G100
CABA	CABALETTA BIO INC	2,110,401	$47,906	18.8%	$3.64	+361.8%	COM	12674W109
—	MERUS N V	1,135,225	$31,219	12.3%	$24.66	—	COM	N5749R100
TCRX	TSCAN THERAPEUTICS INC	5,224,600	$30,459	12.0%	$2.68	+70.9%	COM	89854M101
CCCC	C4 THERAPEUTICS INC	3,134,396	$17,709	7.0%	$2.53	-9.9%	COM STK	12529R107
STOK	STOKE THERAPEUTICS INC	2,956,918	$15,553	6.1%	$5.61	-23.7%	COM	86150R107
AUTL	AUTOLUS THERAPEUTICS PLC	1,858,409	$11,968	4.7%	$3.43	—	SPON ADS	05280R100
GHRS	GH RESEARCH PLC	1,838,617	$10,664	4.2%	$9.07	-22.2%	ORDINARY SHARES	G3855L106
—	KINNATE BIOPHARMA INC	1,997,006	$4,733	1.9%	$10.62	—	COM	49705R105
SLN	SILENCE THERAPEUTICS PLC	235,787	$4,096	1.6%	$9.82	—	ADS	82686Q101
—	THESEUS PHARMACEUTICALS INC	702,415	$2,845	1.1%	$8.59	—	COM	88369M101
—	PIERIS PHARMACEUTICALS INC	9,775,849	$1,779	0.7%	$1.23	—	COM	720795103
—	BIONOMICS LIMITED	824,305	$1,220	0.5%	$2.69	—	ADS	09063M205
—	NEKTAR THERAPEUTICS	1,929,198	$1,090	0.4%	$0.59	—	COM	640268108
—	PASSAGE BIO INC	379,159	$383	0.2%	$1.22	—	COM	702712100